Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 971345, 14 pages
http://dx.doi.org/10.1155/2014/971345
Research Article

Novel Bifunctional Single-Chain Variable Antibody Fragments to Enhance Virolysis by Complement: Generation and Proof-of-Concept

1Division of Virology, Innsbruck Medical University, Peter-Mayr-Straße 4b, 6020 Innsbruck, Austria
2Department of Biotechnology, VIBT, BOKU-University of Natural Resources and Life Sciences, Muthgasse 11, 1190 Vienna, Austria

Received 7 August 2013; Accepted 3 October 2013; Published 12 January 2014

Academic Editor: Lucia Lopalco

Copyright © 2014 Georg Huber et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Kaur, G. Venktaraman, M. Jain, S. Senapati, P. K. Garg, and S. K. Batra, “Recent trends in antibody-based oncologic imaging,” Cancer Letters, vol. 315, no. 2, pp. 97–111, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. A. D. Ricart, “Immunoconjugates against solid tumors: mind the gap,” Clinical Pharmacology and Therapeutics, vol. 89, no. 4, pp. 513–523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Maneewatch, J. Thanongsaksrikul, T. Songserm et al., “Human single-chain antibodies that neutralize homologous and heterologous strains and clades of influenza A virus subtype H5N1,” Antiviral Therapy, vol. 14, no. 2, pp. 221–230, 2009. View at Google Scholar · View at Scopus
  4. M. D. Sørensen, B. Sørensen, R. Gonzalez-Dosal et al., “Severe acute respiratory syndrome (SARS): development of diagnostics and antivirals,” Annals of the New York Academy of Sciences, vol. 1067, no. 1, pp. 500–505, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Das, J. Kriangkum, L. P. Nagata, R. E. Fulton, and M. R. Suresh, “Development of a biotin mimic tagged ScFv antibody against western equine encephalitis virus: bacterial expression and refolding,” Journal of Virological Methods, vol. 117, no. 2, pp. 169–177, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. O. Poungpair, W. Chaicumpa, K. Kulkeaw et al., “Human single chain monoclonal antibody that recognizes matrix protein of heterologous influenza A virus subtypes,” Journal of Virological Methods, vol. 159, no. 1, pp. 105–111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Jurado, D. Ritz, J. Beckwith, V. de Lorenzo, and L. A. Fernández, “Production of functional single-chain Fv antibodies in the cytoplasm of Escherichia coli,” Journal of Molecular Biology, vol. 320, no. 1, pp. 1–10, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Sonoda, Y. Kumada, T. Katsuda, and H. Yamaji, “Functional expression of single-chain Fv antibody in the cytoplasm of Escherichia coli by thioredoxin fusion and co-expression of molecular chaperones,” Protein Expression and Purification, vol. 70, no. 2, pp. 248–253, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Q. Schmidt, A. P. Herbert, H. G. Hocking, D. Uhrín, and P. N. Barlow, “Translational mini-review series on complement factor H: structural and functional correlations for factor H,” Clinical and Experimental Immunology, vol. 151, no. 1, pp. 14–24, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Frank, H. Stoiber, S. Godar et al., “Acquisition of host cell-surface-derived molecules by HIV-1,” AIDS, vol. 10, no. 14, pp. 1611–1620, 1996. View at Google Scholar · View at Scopus
  11. S. Doepper, L. Kacani, B. Falkensammer, M. P. Dierich, and H. Stoiber, “Complement receptors in HIV infection,” Current Molecular Medicine, vol. 2, no. 8, pp. 703–711, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Stoiber, C. Pintér, A. G. Siccardi, A. Clivio, and M. P. Dierich, “Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55),” Journal of Experimental Medicine, vol. 183, no. 1, pp. 307–310, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. K. J. Hasenkrug and U. Dittmer, “Immune control and prevention of chronic friend retrovirus infection,” Frontiers in Bioscience, vol. 12, no. 4, pp. 1544–1551, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. E. A. Kabat and T. T. W. Tai Te Wu, “Identical V region amino acid sequences and segments of sequences in antibodies of different specificities: relative contributions of V(H) and V(L) genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites,” Journal of Immunology, vol. 147, no. 5, pp. 1709–1719, 1991. View at Google Scholar · View at Scopus
  15. A. Roy, A. Kucukural, and Y. Zhang, “I-TASSER: a unified platform for automated protein structure and function prediction,” Nature protocols, vol. 5, no. 4, pp. 725–738, 2010. View at Google Scholar · View at Scopus
  16. B. G. Pierce, Y. Hourai, and Z. Weng, “Accelerating protein docking in ZDOCK using an advanced 3D convolution library,” PLoS ONE, vol. 6, no. 9, Article ID e24657, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. W. J. Britt and B. Chesebro, “Use of monoclonal anti-gp70 antibodies to mimic the effects of the Rfv-3 gene in mice with Friend virus-induced leukemia,” Journal of Immunology, vol. 130, no. 5, pp. 2363–2367, 1983. View at Google Scholar · View at Scopus
  18. T. Kristensen and B. F. Tack, “Murine protein H is comprised of 20 repeating units, 61 amino acids in length,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 11, pp. 3963–3967, 1986. View at Google Scholar · View at Scopus
  19. Invitrogen, “pPICZa A, B, and C,” 2010.
  20. S. Linder, M. Schliwa, and E. Kube-Granderath, “Direct PCR screening of Pichia pastoris clones,” BioTechniques, vol. 20, no. 6, pp. 980–982, 1996. View at Google Scholar · View at Scopus
  21. Invitrogen, “Pichia fermentation guidelines,” 2002.
  22. M. Huber, V. von Wyl, C. G. Ammann et al., “Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linked,” Journal of Virology, vol. 82, no. 8, pp. 3834–3842, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. J. Perkins, R. Nan, A. I. Okemefuna, K. Li, S. Khan, and A. Miller, “Multiple interactions of complement factor h with its ligands in solution: a progress report,” Advances in Experimental Medicine and Biology, vol. 703, pp. 25–47, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Fischer, J. K. Wong, D. Russenberger et al., “Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcripts,” Antiviral Therapy, vol. 7, no. 2, pp. 91–103, 2002. View at Google Scholar · View at Scopus
  25. U. Dittmer, H. He, R. J. Messer et al., “Functional impairment of CD8+ T cells by regulatory T cells during persistent retroviral infection,” Immunity, vol. 20, no. 3, pp. 293–303, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. M. N. Robertson, M. Miyazawa, S. Mori et al., “Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: use in a focal infectivity assay, immunohistochemical studies, electron microscopy and Western blotting,” Journal of Virological Methods, vol. 34, no. 3, pp. 255–271, 1991. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Fass, R. A. Davey, C. A. Hamson, P. S. Kim, J. M. Cunningham, and J. M. Berger, “Structure of a murine leukemia virus receptor-binding glycoprotein 2.0 angstrom resolution,” Science, vol. 277, no. 5332, pp. 1662–1666, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. PyMOL, “The PyMOL Molecular Graphics System,” Schrödinger, LCC.
  29. S. Sommaruga, A. Lombardi, A. Salvadè et al., “Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cells,” Applied Microbiology and Biotechnology, vol. 91, no. 3, pp. 613–621, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. Z.-Z. Cheng, J. Hellwage, H. Seeberger, P. F. Zipfel, S. Meri, and T. S. Jokiranta, “Comparison of surface recognition and C3b binding properties of mouse and human complement factor H,” Molecular Immunology, vol. 43, no. 7, pp. 972–979, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. D. R. Higgins and J. M. Cregg, “Introduction to Pichia pastoris,” Methods in Molecular Biology, vol. 103, pp. 1–15, 1998. View at Google Scholar · View at Scopus
  32. J. M. Cregg, T. S. Vedvick, and W. C. Raschke, “Recent advances in the expression of foreign genes in Pichia pastoris,” BioTechnology, vol. 11, no. 8, pp. 905–910, 1993. View at Publisher · View at Google Scholar · View at Scopus
  33. X. Shi, T. Karkut, M. Chamankhah, M. Alting-Mees, S. M. Hemmingsen, and D. Hegedus, “Optimal conditions for the expression of a single-chain antibody (scFv) gene in Pichia pastoris,” Protein Expression and Purification, vol. 28, no. 2, pp. 321–330, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. Li, F. Xiong, Q. Lin et al., “Low-temperature increases the yield of biologically active herring antifreeze protein in Pichia pastoris,” Protein Expression and Purification, vol. 21, no. 3, pp. 438–445, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. L. M. Albritton, L. Tseng, D. Scadden, and J. M. Cunningham, “A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection,” Cell, vol. 57, no. 4, pp. 659–666, 1989. View at Google Scholar · View at Scopus
  36. J. A. Carmichael, B. E. Power, T. P. J. Garrett et al., “The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in VL-to-VH orientation: implications for diabody flexibility,” Journal of Molecular Biology, vol. 326, no. 2, pp. 341–351, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Hust, T. Jostock, C. Menzel et al., “Single chain Fab (scFab) fragment,” BMC Biotechnology, vol. 7, article 14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. N. K. Khatri, D. Gocke, O. Trentmann, P. Neubauer, and F. Hoffmann, “Single-chain antibody fragment production in Pichia pastoris: benefits of prolonged pre-induction glycerol feeding,” Biotechnology Journal, vol. 6, no. 4, pp. 452–462, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Jungo, I. Marison, and U. von Stockar, “Mixed feeds of glycerol and methanol can improve the performance of Pichia pastoris cultures: a quantitative study based on concentration gradients in transient continuous cultures,” Journal of Biotechnology, vol. 128, no. 4, pp. 824–837, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. J. M. Cregg, J. L. Cereghino, J. Shi, and D. R. Higgins, “Recombinant protein expression in Pichia pastoris,” Applied Biochemistry and Biotechnology, vol. 16, no. 1, pp. 23–52, 2000. View at Google Scholar · View at Scopus
  41. H. Panjideh, V. Coelho, J. Dernedde et al., “Production of bifunctional single-chain antibody-based fusion proteins in Pichia pastoris supernatants,” Bioprocess and Biosystems Engineering, vol. 31, no. 6, pp. 559–568, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Yamawaki, T. Matsumoto, Y. Ohnishi et al., “Production of single-chain variable fragment antibody (scFv) in fed-batch and continuous culture of Pichia pastoris by two different methanol feeding methods,” Journal of Bioscience and Bioengineering, vol. 104, no. 5, pp. 403–407, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Hörl, Z. Banki, G. Huber et al., “Complement factor H-derived short consensus repeat 18–20 enhanced complement-dependent cytotoxicity of Ofatumumab on chronic lymphocytic leukemia cells,” Haematologica, 2013. View at Publisher · View at Google Scholar
  44. S. Hörl, Z. Bلnki, G. Huber et al., “Reduction of complement factor H binding to CLL cells improves the induction of rituximab-mediated complement-dependent cytotoxicity,” Leukemia, vol. 27, pp. 2200–2208, 2013. View at Publisher · View at Google Scholar
  45. F. Förster, O. Medalia, N. Zauberman, W. Baumeister, and D. Fass, “Retrovirus envelope protein complex structure in situ studied by cryo-electron tomography,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 13, pp. 4729–4734, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. U. Dittmer and K. J. Hasenkrug, “Different immunological requirements for protection against acute versus persistent friend retrovirus infections,” Virology, vol. 272, no. 1, pp. 177–182, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Zavorotinskaya and L. M. Albritton, “A hydrophobic patch in ecotropic murine leukemia virus envelope protein is the putative binding site for a critical tyrosine residue on the cellular receptor,” Journal of Virology, vol. 73, no. 12, pp. 10164–10172, 1999. View at Google Scholar · View at Scopus